Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saskia Middeldorp

Showing results (101-110 of 342) with videos related to

Pageof 35
Sort By:
BMJ Open|October 22, 2020
Women's health in <i>The BMJ</i>: a data science historyEva N Hamulyák, Austin J Brockmeier, Johanna D Killas, et al.
British Journal of Haematology|October 22, 2015
In vivo reversal of the anticoagulant effect of rivaroxaban with four-factor prothrombin complex concentrateStefano Barco, Y Whitney Cheung, Michiel Coppens, et al.
Pregnancy Hypertension|March 4, 2019
Creatine kinase and blood pressure in women with a history of early-onset preeclampsiaDeborah L Horjus, Anouk Bokslag, Femke Hooijberg, et al.
Pathophysiology of Haemostasis and Thrombosis|December 8, 2004
Acquired and inherited thrombophilic factors and the risk for residual venous thrombosisIvan Bank, Lidwien W Tick, Barbara A Hutten, et al.
Thrombosis Research|August 15, 2015
Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonistsNico De Crem, Kathelijne Peerlinck, Thomas Vanassche, et al.
Journal of Thrombosis and Thrombolysis|May 26, 2017
Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysisMarjolein P A Brekelmans, Kim van Ginkel, Joost G Daams, et al.
Blood|January 31, 2015
A novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant functionMarisa L R Cunha, Kamran Bakhtiari, Jorge Peter, et al.
Chest|February 9, 2012
VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesShannon M Bates, Ian A Greer, Saskia Middeldorp, et al.
Blood Advances|August 25, 2021
Pregnancy in women with an inferior vena cava filter: a tertiary center experience and overview of the literatureIngrid M Bistervels, Abby E Geerlings, Peter I Bonta, et al.
Journal of Thrombosis and Haemostasis : JTH|March 7, 2022
Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolismIngrid M Bistervels, Roisin Bavalia, Martin Gebel, et al.
Pageof 35

Showing results (101-110 of 342) with videos related to

Sort By:
Pageof 35
BMJ Open|October 22, 2020
Women's health in <i>The BMJ</i>: a data science historyEva N Hamulyák, Austin J Brockmeier, Johanna D Killas, et al.
British Journal of Haematology|October 22, 2015
In vivo reversal of the anticoagulant effect of rivaroxaban with four-factor prothrombin complex concentrateStefano Barco, Y Whitney Cheung, Michiel Coppens, et al.
Pregnancy Hypertension|March 4, 2019
Creatine kinase and blood pressure in women with a history of early-onset preeclampsiaDeborah L Horjus, Anouk Bokslag, Femke Hooijberg, et al.
Pathophysiology of Haemostasis and Thrombosis|December 8, 2004
Acquired and inherited thrombophilic factors and the risk for residual venous thrombosisIvan Bank, Lidwien W Tick, Barbara A Hutten, et al.
Thrombosis Research|August 15, 2015
Abnormal uterine bleeding in VTE patients treated with rivaroxaban compared to vitamin K antagonistsNico De Crem, Kathelijne Peerlinck, Thomas Vanassche, et al.
Journal of Thrombosis and Thrombolysis|May 26, 2017
Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysisMarjolein P A Brekelmans, Kim van Ginkel, Joost G Daams, et al.
Blood|January 31, 2015
A novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant functionMarisa L R Cunha, Kamran Bakhtiari, Jorge Peter, et al.
Chest|February 9, 2012
VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesShannon M Bates, Ian A Greer, Saskia Middeldorp, et al.
Blood Advances|August 25, 2021
Pregnancy in women with an inferior vena cava filter: a tertiary center experience and overview of the literatureIngrid M Bistervels, Abby E Geerlings, Peter I Bonta, et al.
Journal of Thrombosis and Haemostasis : JTH|March 7, 2022
Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolismIngrid M Bistervels, Roisin Bavalia, Martin Gebel, et al.
Pageof 35